Refine
Latest round
- Series C
Last raised
- Dec 2025
Total raised
- $30M
Investors
- 6
About Refine
, trading as Refine, is a national high-tech enterprise specializing in the extraction and technological development of active plant ingredients. The company is headquartered in Beijing and has 3 production bases and 2 research and development center in Shanghai and Beijing. Refine is also the sugar substitute supplier of Yuanqi Forest. In recent years, with improvements in product quality and specifications, its customer base has expanded from a single market to include Europe, Australia, and Southeast Asia. The company has also diversified from simple crude processing and trading of traditional Chinese medicinal materials to the research and processing of extracts and formulations, focusing on providing high-quality products and services to customers in the food and beverage, health products, cosmetics, personal care, and animal feed industries. It boasts a GMP-standard production facility and offers standardized extracts of magnolia bark, epimedium, marigold, rhodiola, ginkgo, and other plants. These extracts are primarily used in the food and beverage, health supplement, cosmetics, personal care, and animal feed industries. The company also provides product testing services including species identification, active ingredient testing, pesticide residue testing, and heavy metal testing. The company generates revenue by doing R&D, and providing plant active ingredient extraction and other related services. In the future, the company will continue to strengthen its technological foundation and empower the global food industry, providing consumers with healthier, more nutritious, and greener compound flavor solutions.
Who invested in Refine
6 investors across 3 rounds
See all investors in Refine
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Refine
Who invested in Refine?
Refine has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Refine raised?
Refine has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Refine last raise money?
Refine's most recent round on record is a Series C, in Dec 2025.
What does Refine do?
, trading as Refine, is a national high-tech enterprise specializing in the extraction and technological development of active plant ingredients.
Where is Refine headquartered?
Refine is headquartered in Beijing, China.
Which VCs invest in companies like Refine?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Refine's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Refine? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.